e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
New data on established treatments for COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study
Vincent Yi-Fong Su (Taipei, Taiwan), Vincent Yi-Fong Su
Source:
International Congress 2015 – New data on established treatments for COPD
Session:
New data on established treatments for COPD
Session type:
Poster Discussion
Number:
1494
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vincent Yi-Fong Su (Taipei, Taiwan), Vincent Yi-Fong Su. Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study. Eur Respir J 2015; 46: Suppl. 59, 1494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
LATE-BREAKING ABSTRACT: Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: the SHIFT trial analysis
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Heart rhythm disorders in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014
Telerehabilitation in people with chronic obstructive pulmonary disease (COPD): A randomised controlled trial
Source: International Congress 2016 – Best abstracts in physical activity and telemedicine
Year: 2016
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Use of beta-blockers in COPD patients with heart-disease. BBEPOC study
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept